Trial intelligence / Profile preview

Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans

NCT02537314Phase 1Completed

Sponsor
Vanderbilt University Medical Center
Start
Sep 2015
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of benzocaine in obesity (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Gastrointestinal Hormones at 5 Hours, Pancreatic Hormones at 5 Hours and 1 more. Started Sep 2015; status: completed.

02

Drugs

benzocaine
03

Conditions

obesity

Beyond the preview

Go deeper on NCT02537314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02537314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call